Dr. Michael Trimble, in collaboration with several other scientists, is spearheading a breakthrough research project focused on whole-genome sequencing. This project, launched by Fraser Health and Simon Fraser University (SFU), is poised to transform the way researchers and healthcare professionals combat superbugs – microscopic organisms resistant to most medications, rendering them particularly challenging to manage. The Lancet’s recent publication disclosed that superbugs upon unchecked growth, are estimated to claim over 39 million lives between 2025 and 2050, delineating an escalating crisis of antimicrobial resistance.
To counter this threat, B.C. researchers have orchestrated a primary pilot program aimed to drastically ameliorate our current knowledge of the behavior and spread of superbugs within hospitals, influencing future counter strategies that will enhance patient safety across varying geographies. Their studies primarily target the Clostridioides difficile (C. difficile) infection, which Fraser Health identifies as one of the key instigators of infectious diarrhea in hospitals and prolonged care institutions.
For this formidable task, the research team, under the guidance of Fraser Health’s Executive Director for Antimicrobial Stewardship and Infection Control, Dr. Kevin Afra, has started acquiring samples from infected patients at the Abbotsford Regional Hospital. The collected samples will undergo whole-genome sequencing for a more comprehensive understanding of C. difficile’s genetic compositions. This data-driven insight will pave the way for determining if the bacteria’s transmissions are patient-dependent or if patients admitted into hospitals are already colonized with this superbug.
SFU’s Dr. Will Hsiao, an integral part of this project, emphasizes the global repercussions of this study. ‘By leveraging advanced computational analysis of the sequence data, we can comprehend C. difficile in a national and global context, which would help healthcare professionals enhance their local intervention strategies accordingly,’ said Dr. Hsiao. Scheduled for the better part of 2026, this study is set to be carried out at SFU’s molecular biology and biochemistry department, promising exciting and critical insights into infection control and prevention.